Jagsonpal Pharmaceuticals (BOM:507789) E10: ₹3.28 (As of Mar. 2026)


BOM:507789 Jagsonpal Pharmaceuticals Ltd BOM:507789
68 GF Score
Price ₹236.05
GF Value ₹205.10
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Jagsonpal Pharmaceuticals E10?

Jagsonpal Pharmaceuticals BOM:507789 +0.36% 68 E10 is ₹3.28 as of Mar. 2026. GuruFocus rates BOM:507789 with a GF Score™ of 68/100 and a GF Value™ of ₹205.10 (Modestly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Jagsonpal Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹1.210. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹3.28 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Jagsonpal Pharmaceuticals's average E10 Growth Rate was 25.70% per year. During the past 3 years, the average E10 Growth Rate was 30.70% per year. During the past 5 years, the average E10 Growth Rate was 30.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Jagsonpal Pharmaceuticals was 34.60% per year. The lowest was 25.10% per year. And the median was 30.70% per year.

As of today (2026-07-05), Jagsonpal Pharmaceuticals's current stock price is ₹236.05. Jagsonpal Pharmaceuticals's E10 for the quarter that ended in Mar. 2026 was ₹3.28. Jagsonpal Pharmaceuticals's Shiller PE Ratio of today is 71.97.

During the past 13 years, the highest Shiller PE Ratio of Jagsonpal Pharmaceuticals was 148.51. The lowest was 19.49. And the median was 80.80.


Jagsonpal Pharmaceuticals  (BOM:507789) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Jagsonpal Pharmaceuticals's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=236.05/3.28
=71.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Jagsonpal Pharmaceuticals was 148.51. The lowest was 19.49. And the median was 80.80.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Jagsonpal Pharmaceuticals E10 Related Terms


Jagsonpal Pharmaceuticals E10 Historical Data

* Premium members only.

The historical data trend for Jagsonpal Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jagsonpal Pharmaceuticals E10 Chart

Jagsonpal Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.07 1.47 1.78 2.61 3.28

Jagsonpal Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.61 2.79 3.01 3.19 3.28

BOM:507789 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jagsonpal Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jagsonpal Pharmaceuticals Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jagsonpal Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Jagsonpal Pharmaceuticals's Shiller PE Ratio falls into.


BOM:507789
68GF Score
Jagsonpal Pharmaceuticals Ltd BOM:507789
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jagsonpal Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jagsonpal Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.21/164.2724*164.2724
=1.210

Current CPI (Mar. 2026) = 164.2724.

Jagsonpal Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201606 0.096 105.961 0.149
201609 0.076 105.961 0.118
201612 1.512 105.196 2.361
201703 0.124 105.196 0.194
201706 -0.644 107.109 -0.988
201709 -0.588 109.021 -0.886
201712 -0.344 109.404 -0.517
201803 -0.188 109.786 -0.281
201806 0.112 111.317 0.165
201809 0.272 115.142 0.388
201812 0.268 115.142 0.382
201903 0.452 118.202 0.628
201906 0.304 120.880 0.413
201909 0.308 123.175 0.411
201912 0.348 126.235 0.453
202003 0.236 124.705 0.311
202006 0.384 127.000 0.497
202009 0.612 130.118 0.773
202012 0.828 130.889 1.039
202103 0.776 131.771 0.967
202106 1.044 134.084 1.279
202109 1.004 135.847 1.214
202112 0.808 138.161 0.961
202203 0.064 138.822 0.076
202206 0.448 142.347 0.517
202209 1.588 144.661 1.803
202212 1.188 145.763 1.339
202303 0.856 146.865 0.957
202306 1.140 150.280 1.246
202309 1.136 151.492 1.232
202312 0.236 152.924 0.254
202403 0.537 153.035 0.576
202406 0.770 155.789 0.812
202409 1.580 157.882 1.644
202412 4.740 158.323 4.918
202503 0.980 157.552 1.022
202506 1.580 159.755 1.625
202509 1.870 162.289 1.893
202512 1.650 163.281 1.660
202603 1.210 164.272 1.210

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹3.28 mean?
Jagsonpal Pharmaceuticals (BOM:507789) has a E10 of ₹3.28 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Jagsonpal Pharmaceuticals and its competitors.
Is Jagsonpal Pharmaceuticals' E10 too high?
Jagsonpal Pharmaceuticals' current E10 is ₹3.28. Overall, Jagsonpal Pharmaceuticals has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jagsonpal Pharmaceuticals' E10 compare to ZTS and UTHR?
Jagsonpal Pharmaceuticals' E10 of ₹3.28 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Jagsonpal Pharmaceuticals and its competitors. Jagsonpal Pharmaceuticals's current E10 is ₹3.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jagsonpal Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Jagsonpal Pharmaceuticals (BOM:507789) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹205.10, compared to a current price of ₹236.05 — trading 15.1% above its estimated fair value. The current E10 is ₹3.28. Jagsonpal Pharmaceuticals' overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Jagsonpal Pharmaceuticals (BOM:507789), the current E10 is ₹3.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jagsonpal Pharmaceuticals (BOM:507789) Overvalued in 2026?

Based on GuruFocus' analysis, Jagsonpal Pharmaceuticals stock appears to be overvalued. The current stock price of ₹236.05 is trading 15.1% above its estimated GF Value™ of ₹205.10. GuruFocus considers Jagsonpal Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for BOM:507789:

  • E10: ₹3.28
  • GF Value™: ₹205.10 vs. price of ₹236.05 (15.1% above fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the BOM:507789 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jagsonpal Pharmaceuticals Business Description

Other Exchanges JAGSNPHARM:India
Address 3rd Floor, Phase - IV, Udyog Vihar, Plot No. 412-415, Nimai Tower, Gurugram, HR, IND, 122015
Jagsonpal Pharmaceuticals Ltd is a pharmaceutical company. It develops and manufactures active pharmaceutical ingredients and formulations like Capsule and Tablet. The company operates in the Gynaecology, Orthopaedics, Dermatology and Paediatric segments. Its brands comprise Lycored, Maintane, Doxypal DR, and others.
68GF Score

Get the complete analysis for BOM:507789

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹236.05
Price
₹205.10
GF Value